6533b856fe1ef96bd12b292a

RESEARCH PRODUCT

Pulmonary metastasectomy in soft tissue sarcomas: a systematic review

Davor StamenovicEric Dominic RoessnerPeter Hohenberger

subject

Pulmonary and Respiratory MedicineLeiomyosarcomamedicine.medical_specialtybusiness.industrySoft tissue sarcomaOriginal Article on Pulmonary MetastasesSoft tissueRetrospective cohort studymedicine.diseaseSynovial sarcomaMetastasisMedicineRadiologyMetastasectomybusinessSurvival rate

description

Background Soft tissue sarcoma (STS) tend to metastasis to the lungs. Pulmonary metastasectomy seems to be a common practice always when plausible. The objective of this article was to review systematically the results of a literature search on pulmonary metastasectomy for STSs published in the last ten years and to offer a brief overview about the current practice as well. Methods Eight retrospective studies published in the period 2010-2020, which included patients with pulmonary metastases and metastasectomy were selected. Indication for surgery, survival rate and factors influencing survival were the primary outcomes, while further interesting findings in the studies were also collected and evaluated. Results Cumulative 1,004 patients participated in these studies. The most common histological types were leiomyosarcoma, malignant fibrous histiocytoma (MFH) and synovial sarcoma, being present together at 60% of the study population. Five-year survival was reported to be in the range from 20-58%, better survival going along with a fewer (preferably one) metastases, longer disease free interval (DFI) and R0 resection in most of the cases. Conclusions Complete resection of the metastatic lesions seems to be the most effective treatment for long-term survival, or even achieving cure in selected patients. At selection of the patients amenable for surgery, a high probability of R0 resection, as well as a disease free period of at least 12 months should perhaps bear a higher specific value.

https://doi.org/10.21037/jtd-2019-pm-13